Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Location
830 Winter Street, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 484 % +2.16%
Debt-to-equity -1.12K % -131%
Return On Equity 580 % +97.1%
Return On Assets -57 % -0.71%
Operating Margin 528 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.3M shares +1.02%
Common Stock, Shares, Outstanding 12.3M shares +1.36%
Entity Public Float 136M USD +198%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares +1.36%
Weighted Average Number of Shares Outstanding, Diluted 12.2M shares +1.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 1.16M USD -64%
Research and Development Expense 26.4M USD -42.6%
General and Administrative Expense 17.1M USD +1.97%
Operating Income (Loss) -43.5M USD +43.8%
Nonoperating Income (Expense) 1.43M USD -92.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.1M USD -7369%
Income Tax Expense (Benefit) 21K USD -94.5%
Net Income (Loss) Attributable to Parent -42.1M USD +30.5%
Earnings Per Share, Basic -5 USD/shares +93%
Earnings Per Share, Diluted 0 USD/shares +58.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49M USD -44.9%
Other Assets, Current 24K USD -89.5%
Assets, Current 50.8M USD -45.9%
Property, Plant and Equipment, Net 1.07M USD -28.2%
Operating Lease, Right-of-Use Asset 5.26M USD -10.4%
Other Assets, Noncurrent 0 USD -100%
Assets 57.8M USD -44.7%
Accounts Payable, Current 973K USD -22.7%
Employee-related Liabilities, Current 1.92M USD -44.6%
Accrued Liabilities, Current 3.91M USD -56.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 11.1M USD -22.8%
Operating Lease, Liability, Noncurrent 5.12M USD -11.6%
Other Liabilities, Noncurrent 55M USD 0%
Liabilities 76.2M USD -11.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -263M USD -19.1%
Stockholders' Equity Attributable to Parent -18.4M USD -201%
Liabilities and Equity 57.8M USD -44.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD +14.2%
Net Cash Provided by (Used in) Financing Activities 99.3M USD +662207%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 12.3M shares +1.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.47M USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49.7M USD -44.6%
Deferred Tax Assets, Valuation Allowance 107M USD +94%
Deferred Tax Assets, Gross 109M USD +90.2%
Operating Lease, Liability 5.79M USD -15.1%
Depreciation 483K USD +22.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.1M USD +30.5%
Lessee, Operating Lease, Liability, to be Paid 7.33M USD -16.9%
Property, Plant and Equipment, Gross 2.82M USD +0.07%
Operating Lease, Liability, Current 671K USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.09M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 265K USD -61.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.53M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.12M USD +2.93%
Deferred Tax Assets, Operating Loss Carryforwards 88.6M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.16M USD +3.03%
Additional Paid in Capital 244M USD +2.24%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 5.04M USD +37.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares